Inventor · disambiguated record
Steven B. Landau
Also filed as: LANDAU STEVEN · LANDAU STEVEN B
10 granted patents·37 pending applications·124 citations·filing 2004–2022
89Inventor score
Files withDYNOGEN PHARMACEUTICALS INC19DYNOGEN INC6EDUSA PHARMACEUTICALS INC4LANDAU STEVEN B4TENSHA THERAPEUTICS INC3
Top patents by PatentIndex Score
47 records- 0195US7041704B2Methods of treating gastrointestinal tract disorders using sodium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2005·Granted May 9, 2006·34 cites·9 claims
- 0291US6846823B2Method of treating lower urinary tract disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted Jan 25, 2005·50 cites·62 claims
- 0384US10918610B2Compounds and methods of promoting myelinationUNIV CASE WESTERN RESERVE·Filed 2018·Granted Feb 16, 2021·2 cites·2 claims
- 0480US7125848B2Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted Oct 24, 2006·9 cites·14 claims
- 0579US7115606B2Method of treating lower urinary tract disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted Oct 3, 2006·11 cites·16 claims
- 0678US7094786B2Method of treating nausea, vomiting, retching or any combination thereofDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted Aug 22, 2006·12 cites·3 claims
- 0776US10124009B2Bromodomain inhibitorsTENSHA THERAPEUTICS INC·Filed 2015·Granted Nov 13, 2018·4 cites·10 claims
- 0874US12403104B2Compounds and methods of promoting myelinationUNIV CASE WESTERN RESERVE·Filed 2022·Granted Sep 2, 2025·0 cites·10 claims
- 0973US2010152231A1Compositions Useful For Treating Irritable Bowel SyndromeEDUSA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1071US11344511B2Compounds and methods of promoting myelinationUNIV CASE WESTERN RESERVE·Filed 2017·Granted May 31, 2022·1 cites·6 claims
- 1169US2008269276A1Compositions useful for treating irritable bowel syndromeDYNOGEN PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1266US10925881B2Treatment of conditions associated with hyperinsulinaemiaTENSHA THERAPEUTICS INC·Filed 2015·Granted Feb 23, 2021·1 cites·16 claims
- 1360US2008275080A1Methods for treating lower urinary tract disorders using alpha2delta subunit channel modulators with smooth muscle modulatorsDYNOGEN PHARMACUETICALS INC·Filed 2008·Application pending·0 cites
- 1460US2009131471A1Compositions useful for treating gastroesophageal reflux diseaseDYNOGEN PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1560US2008085916A1Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1660US2009048287A1Compositions useful for treating gastrointestinal motility disordersLANDAU STEVEN B·Filed 2008·Application pending·0 cites
- 1759US2006217391A1Method of treating functional bowel disordersLANDAU STEVEN B·Filed 2006·Application pending·0 cites
- 1858US2004213842A1Methods of treating gastrointestinal tract disorders using sodium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1958US2005032780A1Method of treating functional bowel disordersDYNOGEN INC·Filed 2004·Application pending·0 cites
- 2057US2005192270A1Methods of decreasing intestinal motilityDYNOGEN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2157US2007060652A1Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2257US2004254170A1Method of treating functional bowel disordersDYNOGEN INC·Filed 2004·Application pending·0 cites
- 2357US2011269792A1Compositions useful for treating irritable bowel syndromeEDUSA PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 2457US2004259862A1Method of treating functional bowel disordersDYNOGEN INC·Filed 2004·Application pending·0 cites
- 2557US2004147509A1Method of treating functional bowel disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2657US2004254169A1Method of treating functional bowel disordersDYNOGEN INC·Filed 2004·Application pending·0 cites
- 2757US2004254168A1Method of treating functional bowel disordersDYNOGEN INC·Filed 2004·Application pending·0 cites
- 2856US2006247311A1Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2955US2005113421A1Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating non-inflammatory gastrointestinal tract disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3055US2005059704A1Compositions useful for treating gastrointestinal motility disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3154US2005239890A1Methods for decreasing detrusor muscle overactivityDYNOGEN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3254US2004248979A1Method of treating lower urinary tract disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3354US2006189648A1Compositions useful for increasing lower esophageal sphincter pressureLANDAU STEVEN B·Filed 2006·Application pending·0 cites
- 3453US2005282799A1Method of treating lower urinary tract disordersDYNOGEN INC·Filed 2005·Application pending·0 cites
- 3553US2005272719A1Method for inhibiting detrusor muscle overactivityLANDAU STEVEN B·Filed 2005·Application pending·0 cites
- 3652US2004198822A1Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulatorsDYNOGEN PHARMACUETICALS INC·Filed 2004·Application pending·0 cites
- 3752US2011294881A1METHODS FOR TREATING LOWER URINARY TRACT DISORDERS USING alpha2delta SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORSFRASER MATTHEW OLIVER·Filed 2011·Application pending·0 cites
- 3851US2007105785A1Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3950US2011275667A1Compositions useful for treating gastroesophageal reflux diseaseEDUSA PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 4049US2004147510A1Method of treating nausea, vomiting, retching or any combination thereofDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 4148US2006276542A1Methods for treating functional bowel disorders using alpha2 subunit calcium channel modulators with smooth muscle modulatorsFRASER MATTHEW O·Filed 2004·Application pending·0 cites
- 4248US2006264509A1Methods for treating pain using smooth muscle modulators and a2 subunit calcium channel modulatorsFRASER MATTHEW O·Filed 2004·Application pending·0 cites
- 4348US2009163442A1Treatment of cancer with 2-deoxygalactoseLANDAU BERNARD R·Filed 2008·Application pending·0 cites
- 4446US2010247584A1Compositions useful for treating gastroesophageal reflux diseaseEDUSA PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4546US2022088050A1Treatment of fatty liver diseaseAVOGADRO DEV CORP·Filed 2020·Application pending·0 cites
- 4645US2018140630A1Combination of an h2-receptor antagonist, antacid, and alginic acid to treat episodic heartburnWOLFE M MICHAEL·Filed 2017·Application pending·0 cites
- 4734US2018193350A1Treatment of nut midline carcinomaTENSHA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven B. Landau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →